Chief Executive Officer
CurrentAIQ is changing how clinicians manage complex diseases, starting with late-stage cancer. AIQ develops novel imaging biomarkers that assess and predict a patient’s response to treatment, including both effectiveness and toxicity. The biomarkers provide more comprehensive and accurate information about treatment response than other approaches. Oncologists.